Insud Pharma
Francisco Manrique is an accomplished legal professional with extensive experience in the pharmaceutical sector, currently serving as Associate General Counsel at Insud Pharma since June 2014, where responsibilities have included roles such as Associate Legal Director for the Pharma business and Head of Legal for Chemo & Xiromed. Additionally, Francisco contributes to academia as a Visiting Lecturer in the Master in Biotechnology and Law program at ISDE since December 2022. Previous experience includes a position as Abogado at Montero-Aramburu Abogados from September 2012 to April 2014. Francisco holds multiple advanced degrees, including a Corporate Development Program from IESE Business School, an Advanced Compliance Program from IEB, an LL.M Master of Laws from IE Business School, and a Law Degree from Universidad Pontificia Comillas, complemented by a diploma in Business Affairs.
This person is not in the org chart
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.